We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Superhemophobic Surfaces Could Enhance Implant Biocompatibility

By HospiMedica International staff writers
Posted on 01 Feb 2017
A new study describes how a specially grown titanium surface that is extremely repellent to blood could lower the risk of medical implant rejection.

Researchers at Colorado State University first analyzed variations of titanium surfaces, including different textures and chemistries, comparing them to define variations in platelet adhesion and activation. More...
They found that only superhemophobic surfaces with a robust Cassie–Baxter state displayed significantly low platelet adhesion and activation. In this state, liquid does not completely wet the surface texture; instead, pockets of air remain trapped underneath the liquid droplet, introducing a composite liquid–air–solid interface.

The researchers achieved the Cassie–Baxter state in titanium surfaces by combining a surface chemistry with low solid surface energy and an appropriate texture created via fluorinated nanotubes. The result was a metastable Cassie–Baxter state that greatly reduced the solid–liquid interfacial area. In fact, the researchers found that the surface was so repellent that blood is deceived into accepting there is almost no foreign material present. The study was published on December 21, 2016, in Advanced Healthcare Materials.

“A material phobic to blood might seem counterintuitive, as often biomedical scientists use materials with affinity to blood to make them biologically compatible,” said senior author professor of mechanical engineering and biomedical engineering Arun Kota, PhD. “What we are doing is the exact opposite. We are taking a material that blood hates to come in contact with, in order to make it compatible with blood.”

“Over time, stents can form clots, obstructions, and lead to heart attacks or embolisms. The reason blood clots is because it finds cells in the blood to go to and attach,” said corresponding author Ketul Popat, PhD. “Normally, blood flows in vessels. If we can design materials where blood barely contacts the surface, there is virtually no chance of clotting, which is a coordinated set of events. Here, we're targeting the prevention of the first set of events.”


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Anesthesia Cart
UTGSU-333369-DKB
New
Multifunctional Patient Floor Lift
Maxi Move 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel AI model boosts early detection and treatment of delirium (Photo courtesy of 123RF)

AI Model Boosts Early Delirium Detection for Improving Health Outcomes of Hospitalized Patients

Delirium, a sudden onset of severe confusion, poses serious life-threatening risks and affects up to one-third of patients in hospitals, often going unnoticed. Without intervention, it can lengthen hospital... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.